Treatment of surgical scars in breast reduction with laser device, to prevent scar hypertrophy.

Withdrawn

• Conditions: excessive scarring; hypertrophic scarring; 10040795; 10014982

• Registration Number: NL-OMON36674
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

- Patients undergoing breast reduction surgery with a wise pattern technique.
- Older than 18 years of age.
- Willing to participate.

Exclusion Criteria

- Dark skin (skin types V or VI, Fitzpatrick Skin Typing Test)
- Pregnant woman
- Malignant tumor skin disease
- Bacterial or viral infectious skin disease
- Immunosuppression (linked to a pathology or specific treatment)
- BMI > 27
- Hart and/or lung disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Outcomes of the Vancouver Scar Scale (VSS) and POSAS score at 12 months after<br /><br>surgery.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Objective scar measures: volume (3D), width, height, colour.<br /><br>Cosmetic appearance. The patient will rate the scar*s overall cosmetic aspect<br /><br>on a visual analogue scale. Two independent plastics surgeons will rate the<br /><br>overall aspect as well on basis of the photographs.<br /><br>Complications.<br /><br>Time course of scar formation using all parameter measures at earlier time<br /><br>points (10 days, 6 weeks, 3 and 6 months after surgery).</p><br>